Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism
Identifieur interne : 004B41 ( Main/Exploration ); précédent : 004B40; suivant : 004B42Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism
Auteurs : Michael Schmidt [Allemagne] ; W. Kurt Roth [Allemagne] ; Hermann Meyer [Allemagne] ; Erhard Seifried [Allemagne] ; Michael K. Hourfar [Allemagne]Source :
- Transfusion [ 0041-1132 ] ; 2005-03.
Abstract
BACKGROUND: Microbiologic agents such as variola virus (VAR) are very attractive for terrorism. As a result of international collaboration under the WHO eradication campaign, smallpox was declared eradicated in 1980. Therefore, the immunization programs were discontinued worldwide. Because most people are now immunologically naive, VAR is considered to be a potential threat agent or bioterrorist weapon. Real‐time polymerase chain reaction (PCR) followed by melting analysis was developed for fast and safe analysis and allows differentiation of VAR from other orthopoxviruses (OPVs) like vaccinia or camelpox virus. STUDY DESIGN AND METHODS: A RealArtTM Orthopox LC PCR kit (Artus GmbH) was used to amplify OPV sequences from blood donor samples. A total of 31,500 blood donor samples were tested in minipools of up to 96 samples. To evaluate the sensitivity of the assay, routine donor minipools (90 ± 6 samples per pool) were spiked with vaccinia virus used as positive control. RESULTS: Specificity was 100 percent because none of 31,500 blood donors was positive for the presence OPV. The detection limit of the assay was 10.6 copies per PCR procedure. Therefore, a sensitivity of 1590 copies per mL was calculated. Overall, 0.28 percent of test results had to be considered invalid owing to negative internal controls. CONCLUSION: The RealArt Orthopox LC PCR kit enables reliable detection of OPV DNA in viremic blood donor samples, even at the beginning of the disease when patients present minor clinical symptoms, and could be implemented in our routine screening procedure immediately. Thus, the assay could potentially help to prevent dispersion of viral agents by blood transfusion in case of bioterrorism.
Url:
DOI: 10.1111/j.1537-2995.2005.04242.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001337
- to stream Istex, to step Curation: 001337
- to stream Istex, to step Checkpoint: 001A02
- to stream Main, to step Merge: 004E69
- to stream Main, to step Curation: 004B41
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism</title><author><name sortKey="Schmidt, Michael" sort="Schmidt, Michael" uniqKey="Schmidt M" first="Michael" last="Schmidt">Michael Schmidt</name></author><author><name sortKey="Roth, W Kurt" sort="Roth, W Kurt" uniqKey="Roth W" first="W. Kurt" last="Roth">W. Kurt Roth</name></author><author><name sortKey="Meyer, Hermann" sort="Meyer, Hermann" uniqKey="Meyer H" first="Hermann" last="Meyer">Hermann Meyer</name></author><author><name sortKey="Seifried, Erhard" sort="Seifried, Erhard" uniqKey="Seifried E" first="Erhard" last="Seifried">Erhard Seifried</name></author><author><name sortKey="Hourfar, Michael K" sort="Hourfar, Michael K" uniqKey="Hourfar M" first="Michael K." last="Hourfar">Michael K. Hourfar</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8ACEAEDF2B4549DCA0817E4AB88B879EE69C49B8</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1111/j.1537-2995.2005.04242.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-57GQHLX4-B/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001337</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001337</idno><idno type="wicri:Area/Istex/Curation">001337</idno><idno type="wicri:Area/Istex/Checkpoint">001A02</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001A02</idno><idno type="wicri:doubleKey">0041-1132:2005:Schmidt M:nucleic:acid:test</idno><idno type="wicri:Area/Main/Merge">004E69</idno><idno type="wicri:Area/Main/Curation">004B41</idno><idno type="wicri:Area/Main/Exploration">004B41</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism</title><author><name sortKey="Schmidt, Michael" sort="Schmidt, Michael" uniqKey="Schmidt M" first="Michael" last="Schmidt">Michael Schmidt</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>From the Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johann Wolfgang Goethe University, Frankfurt; and the Institute of Microbiology of the Bundeswehr, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Allemagne</country></affiliation></author><author><name sortKey="Roth, W Kurt" sort="Roth, W Kurt" uniqKey="Roth W" first="W. Kurt" last="Roth">W. Kurt Roth</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>From the Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johann Wolfgang Goethe University, Frankfurt; and the Institute of Microbiology of the Bundeswehr, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Meyer, Hermann" sort="Meyer, Hermann" uniqKey="Meyer H" first="Hermann" last="Meyer">Hermann Meyer</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>From the Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johann Wolfgang Goethe University, Frankfurt; and the Institute of Microbiology of the Bundeswehr, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Seifried, Erhard" sort="Seifried, Erhard" uniqKey="Seifried E" first="Erhard" last="Seifried">Erhard Seifried</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>From the Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johann Wolfgang Goethe University, Frankfurt; and the Institute of Microbiology of the Bundeswehr, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author><author><name sortKey="Hourfar, Michael K" sort="Hourfar, Michael K" uniqKey="Hourfar M" first="Michael K." last="Hourfar">Michael K. Hourfar</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>From the Institute of Transfusion Medicine and Immunohematology, German Red Cross, Johann Wolfgang Goethe University, Frankfurt; and the Institute of Microbiology of the Bundeswehr, Munich</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Haute-Bavière</region><settlement type="city">Munich</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Transfusion</title><title level="j" type="alt">TRANSFUSION</title><idno type="ISSN">0041-1132</idno><idno type="eISSN">1537-2995</idno><imprint><biblScope unit="vol">45</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="399">399</biblScope><biblScope unit="page" to="403">403</biblScope><biblScope unit="page-count">5</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK and Malden, USA</pubPlace><date type="published" when="2005-03">2005-03</date></imprint><idno type="ISSN">0041-1132</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0041-1132</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">BACKGROUND: Microbiologic agents such as variola virus (VAR) are very attractive for terrorism. As a result of international collaboration under the WHO eradication campaign, smallpox was declared eradicated in 1980. Therefore, the immunization programs were discontinued worldwide. Because most people are now immunologically naive, VAR is considered to be a potential threat agent or bioterrorist weapon. Real‐time polymerase chain reaction (PCR) followed by melting analysis was developed for fast and safe analysis and allows differentiation of VAR from other orthopoxviruses (OPVs) like vaccinia or camelpox virus. STUDY DESIGN AND METHODS: A RealArtTM Orthopox LC PCR kit (Artus GmbH) was used to amplify OPV sequences from blood donor samples. A total of 31,500 blood donor samples were tested in minipools of up to 96 samples. To evaluate the sensitivity of the assay, routine donor minipools (90 ± 6 samples per pool) were spiked with vaccinia virus used as positive control. RESULTS: Specificity was 100 percent because none of 31,500 blood donors was positive for the presence OPV. The detection limit of the assay was 10.6 copies per PCR procedure. Therefore, a sensitivity of 1590 copies per mL was calculated. Overall, 0.28 percent of test results had to be considered invalid owing to negative internal controls. CONCLUSION: The RealArt Orthopox LC PCR kit enables reliable detection of OPV DNA in viremic blood donor samples, even at the beginning of the disease when patients present minor clinical symptoms, and could be implemented in our routine screening procedure immediately. Thus, the assay could potentially help to prevent dispersion of viral agents by blood transfusion in case of bioterrorism.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>Bavière</li><li>District de Haute-Bavière</li></region><settlement><li>Munich</li></settlement></list><tree><country name="Allemagne"><region name="Bavière"><name sortKey="Schmidt, Michael" sort="Schmidt, Michael" uniqKey="Schmidt M" first="Michael" last="Schmidt">Michael Schmidt</name></region><name sortKey="Hourfar, Michael K" sort="Hourfar, Michael K" uniqKey="Hourfar M" first="Michael K." last="Hourfar">Michael K. Hourfar</name><name sortKey="Meyer, Hermann" sort="Meyer, Hermann" uniqKey="Meyer H" first="Hermann" last="Meyer">Hermann Meyer</name><name sortKey="Roth, W Kurt" sort="Roth, W Kurt" uniqKey="Roth W" first="W. Kurt" last="Roth">W. Kurt Roth</name><name sortKey="Schmidt, Michael" sort="Schmidt, Michael" uniqKey="Schmidt M" first="Michael" last="Schmidt">Michael Schmidt</name><name sortKey="Seifried, Erhard" sort="Seifried, Erhard" uniqKey="Seifried E" first="Erhard" last="Seifried">Erhard Seifried</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004B41 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004B41 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8ACEAEDF2B4549DCA0817E4AB88B879EE69C49B8
|texte= Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism
}}
| This area was generated with Dilib version V0.6.33. |  |